Patents by Inventor Gyorgy Ambrus

Gyorgy Ambrus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7491383
    Abstract: Compositions comprising a therapeutic component and an efficacy enhancing component, that enhances the pharmacokinetic disposition of the therapeutic component, are disclosed. The therapeutic component may include an alpha-2-adrenergic agonist and the efficacy enhancing component may include fatty acids. In one embodiment, the therapeutic component and the efficacy enhancing component form a complex.
    Type: Grant
    Filed: May 1, 2002
    Date of Patent: February 17, 2009
    Assignee: Allergan, Inc.
    Inventors: David F. Woodward, Gyorgy Ambrus
  • Publication number: 20070265311
    Abstract: Therapeutic salt compositions and methods are disclosed herein.
    Type: Application
    Filed: January 5, 2007
    Publication date: November 15, 2007
    Inventors: Mark Rubino, Gyorgy Ambrus
  • Publication number: 20070254923
    Abstract: Therapeutic salt compositions and methods are disclosed herein.
    Type: Application
    Filed: May 3, 2007
    Publication date: November 1, 2007
    Inventors: Mark Rubino, Gyorgy Ambrus
  • Publication number: 20030045524
    Abstract: Compositions comprising an alpha-2-adrenergic agonist component and a fatty acid component, that enhances the pharmacokinetic disposition of the therapeutic component, are disclosed. The fatty acid component may include linolenic acid and/or other fatty acids. In a one embodiment, the alpha-2-adrenergic agonist component and the fatty acid component form a complex.
    Type: Application
    Filed: May 1, 2002
    Publication date: March 6, 2003
    Inventors: David F. Woodward, Gyorgy Ambrus
  • Publication number: 20030017199
    Abstract: Compositions comprising a therapeutic component and an efficacy enhancing component, that enhances the pharmacokinetic disposition of the therapeutic component, are disclosed. The therapeutic component may include an alpha-2-adrenergic agonist and the efficacy enhancing component may include fatty acids. In one embodiment, the therapeutic component and the efficacy enhancing component form a complex.
    Type: Application
    Filed: May 1, 2002
    Publication date: January 23, 2003
    Inventors: David F. Woodward, Gyorgy Ambrus
  • Publication number: 20020198209
    Abstract: Compositions comprising a therapeutic component and an efficacy enhancing component that enhances the pharmacokinetic disposition of the therapeutic component is disclosed. In one embodiment, the therapeutic component includes an alpha-2-adrenergic agonist. In another embodiment, the efficacy enhancing components include fatty acids. In a preferred embodiment, the therapeutic component and the efficacy enhancing component forms a complex.
    Type: Application
    Filed: May 3, 2001
    Publication date: December 26, 2002
    Applicant: Allergan Sales Inc.
    Inventors: David F. Woodward, Gyorgy Ambrus
  • Publication number: 20020198210
    Abstract: Alpha-2-Adrenergic Agonist/Fatty Acid Compositions Compositions comprising an alpha-2-adrenergic agonist component and a fatty acid component are disclosed. In one embodiment, the fatty acid components include fatty acids. In a preferred embodiment, the alpha-2-adrenergic agonist component and the fatty acid component forms a complex.
    Type: Application
    Filed: May 3, 2001
    Publication date: December 26, 2002
    Applicant: Allergan Sales Inc.
    Inventors: David F. Woodward, Gyorgy Ambrus